Alpha Tau Medical Ltd.
Business
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company developing localized alpha-particle radiotherapy for solid tumors. It produces the proprietary Alpha DaRT® technology comprising Radium-224–loaded radioactive sources, applicators and treatment kits designed to deliver intratumoral diffusing alpha-emitter radiation. Its operations include clinical development programs across multiple indications (e.g., skin/head & neck, pancreatic, prostate, liver metastases, lung, GBM), manufacturing sites and a pre-clinical laboratory. The company conducts global clinical trials and plans commercialization and distribution primarily in the United States, Europe, Israel, Japan and selected international markets.
Summary from filing dated 2025-03-12
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-42.63M |
| Total assets | $105.65M |
| Total liabilities | $28.55M |
| Stockholders' equity | $77.10M |
| Operating cash flow | $-26.68M |